Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Mads Krogsgaard Thomsen
Age : 60
Public asset : 15,111,261 USD
Country of residence : Unknown
Linked companies : Novo Nordisk A/S - BB Biotech AG

Biography of Mads Krogsgaard Thomsen 
Currently, Mads Krogsgaard Thomsen occupies the position of Chairman for Steno Diabetes Center An and Chief Science Officer & Executive Vice President at Novo Nordisk A. Dr. Thomsen is also on the board of BB Biotech AG and Symphogen An and Chairman of the University of Copenhagen. Dr. Thomsen previously held the position of President at The Danish Academy of Technical Sciences. Dr. Thomsen received a doctorate from the University of Copenhagen.


Current positions of Mads Krogsgaard Thomsen 
Mads Krogsgaard Thomsen : Personal Network 
Most Read News 
06/14ELON MUSK : Bitcoin tops $40,000 after Musk says Tesla could use it again
RE
06/23RAJESH KUMAR : Pass them on
RE
03:25aWARREN BUFFETT : Warren Buffett resigns from Gates Foundation, has donated half his fortune
RE
06/12JEFF BEZOS : Bid of $28 million wins a rocket trip to space with Bezos
RE
06/18PETER THIEL : Thiel-backed psychedelics startup Atai valued at $3.19 billion in Nasdaq debut
RE
02:08aJEFF BEZOS : Bezos' 2021 Space Odyssey a risk too far for insurers
RE
06/11ELON MUSK : 'This car crushes' Musk says, as Tesla launches faster Model S 'Plaid'
RE
06/15JACK MA : Alibaba executive says founder Jack Ma 'lying low' - CNBC
RE
06/21WARREN BUFFETT : Buffett-backed Nubank in talks to hire U.S. IPO underwriters -sources
RE
06/10MARIA MARTINEZ : French Industrial Production Unexpectedly Declined in April
DJ
More news


© 2021 People and Ownership :   
Mads Krogsgaard Thomsen : Connections 


Latest news about Mads Krogsgaard Thomsen 
03/18DGAP-NEWSá : L'Assemblea generale di BB Biotech AG approva tutte le proposte e autorizza il pagamento di un dividendo di CHF 3.60
DJ
03/18PRESS RELEASEá : Shareholders at BB Biotech AG's AGM vote in favor of all proposals and approve the dividend of CHF 3.60 per share
DJ
2020NOVO NORDISK A/Sá : Files For EU Approval of Obesity Drug
DJ
2020NOVO NORDISK A/Sá : to Test Semaglutide in Late-Stage Alzheimer's Disease Study
MT
2020NOVO NORDISK A/Sá : Files FDA New Drug Application for Obesity Drug
DJ
2020NOVO NORDISK A/Sá : to boost pill-form diabetic drugs with $1.8 billion deal
RE
More news